Insight 2811 Inc’s Pfizer PFE Stock Holding History

Insight 2811 Inc’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,632	Closed	-$315K	–	105
2025 Q4	$315K	Hold	12,632	–	–	0.14%	67
2025 Q3	$322K	Buy	12,632 +613	+5%	+$15.1K	0.14%	67
2025 Q2	$291K	Buy	12,019 +400	+3%	+$9.33K	0.14%	68
2025 Q1	$294K	Buy	11,619 +200	+2%	+$5.23K	0.15%	69
2024 Q4	$303K	Hold	11,419	–	–	0.16%	67
2024 Q3	$330K	Hold	11,419	–	–	0.16%	64
2024 Q2	$320K	Hold	11,419	–	–	0.17%	61
2024 Q1	$317K	Hold	11,419	–	–	0.16%	60
2023 Q4	$329K	Hold	11,419	–	–	0.18%	59
2023 Q3	$379K	Sell	11,419 -10	-0.1%	-$354	0.22%	51
2023 Q2	$419K	Buy	11,429 +10	+0.1%	+$389	0.23%	50
2023 Q1	$466K	Sell	11,419 -2,486	-18%	-$107K	0.29%	49
2022 Q4	$712K	Buy	13,905 +864	+7%	+$41.4K	0.44%	29
2022 Q3	$571K	Hold	13,041	–	–	0.38%	28
2022 Q2	$684K	Sell	13,041 -200	-2%	-$10.2K	0.45%	22
2022 Q1	$685K	Sell	13,241 -13,556	-51%	-$703K	0.41%	26
2021 Q4	$1.58M	Sell	26,797 -304	-1%	-$15.1K	0.9%	15
2021 Q3	$1.17M	Sell	27,101 -1,484	-5%	-$65.7K	0.69%	16
2021 Q2	$1.12M	Sell	28,585 -315	-1%	-$12.3K	0.63%	17
2021 Q1	$1.05M	Sell	28,900 -490	-2%	-$17.4K	0.61%	16
2020 Q4	$1.08M	Sell	29,390 -2,673	-8%	-$98K	0.64%	16
2020 Q3	$1.12M	Buy	32,063 +329	+1%	+$11.5K	0.69%	16
2020 Q2	$1.06M	Sell	31,734 -2,580	-8%	-$87.7K	0.7%	16
2020 Q1	$1.06M	Sell	34,314 -3,046	-8%	-$104K	0.78%	15
2019 Q4	$1.39M	Buy	37,360 +1,195	+3%	+$42.6K	0.91%	14
2019 Q3	$1.23M	Sell	36,165 -1,915	-5%	-$69.6K	0.87%	11
2019 Q2	$1.6M	Sell	38,080 -499	-1%	-$19.8K	1.16%	9
2019 Q1	$1.55M	Sell	38,579 -3,810	-9%	-$153K	1.19%	8
2018 Q4	$1.75M	Sell	42,389 -2,295	-5%	-$95.3K	1.49%	8
2018 Q3	$1.87M	Sell	44,684 -1,335	-3%	-$51.4K	1.26%	7
2018 Q2	$1.58M	Sell	46,019 -3,090	-6%	-$106K	1.1%	10
2018 Q1	$1.65M	Buy	49,109 +12,158	+33%	+$418K	1.19%	10
2017 Q4	$1.27M	Sell	36,951 -1,211	-3%	-$41.3K	0.93%	15
2017 Q3	$1.29M	Buy	38,162 +3,132	+9%	+$101K	0.96%	15
2017 Q2	$1.12M	Buy	35,030 +25,203	+256%	+$795K	0.85%	15
2017 Q1	$319K	Buy	9,827 +346	+4%	+$10.9K	0.24%	60
2016 Q4	$292K	Buy	9,481 +793	+9%	+$24.2K	0.24%	54
2016 Q3	$279K	Sell	8,688 -5,697	-40%	-$190K	0.17%	70
2016 Q2	$481K	Sell	14,385 -1,831	-11%	-$58.4K	0.19%	74
2016 Q1	$456K	Sell	16,216 -1,899	-10%	-$54.2K	0.18%	77
2015 Q4	$555K	Hold	18,115	–	–	0.26%	67
2015 Q3	$540K	Sell	18,115 -29	-0.2%	-$930	0.31%	62
2015 Q2	$577K	Sell	18,144 -89	-0.5%	-$2.9K	0.28%	66
2015 Q1	$602K	Sell	18,233 -7,635	-30%	-$243K	0.28%	68
2014 Q4	$765K	Sell	25,868 -411	-2%	-$11.8K	0.37%	54
2014 Q3	$737K	Sell	26,279 -1,130	-4%	-$31.7K	0.32%	60
2014 Q2	$772K	Sell	27,409 -1,244	-4%	-$35.5K	0.32%	60
2014 Q1	$873K	Sell	28,653 -95	-0.3%	-$2.83K	0.37%	51
2013 Q4	$835K	Sell	28,748 -2,741	-9%	-$79.8K	0.41%	41
2013 Q3	$858K	Sell	31,489 -1,790	-5%	-$48.7K	0.43%	45
2013 Q2	$884K	Buy	+33,279	New	+$919K	0.49%	42

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Insight 2811 Inc's PFE Position: Q1 2026 in Review

Insight 2811 Inc sold out of Pfizer (PFE) in Q1 2026, closing a stake of 12,632 shares — an estimated $315K sold.

Insight 2811 Inc first reported a position in PFE in Q2 2013 and held it in 51 quarters. The position peaked at $1.87M in Q3 2018. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Insight 2811 Inc reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
Insight 2811 Inc sold 12,632 Pfizer shares in Q1 2026, an estimated $315K.
Insight 2811 Inc first reported a position in Pfizer in Q2 2013 and held it in 51 quarters.
Insight 2811 Inc's Pfizer position peaked at $1.87M in Q3 2018.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Insight 2811 Inc's 13F filing for Q1 2026, filed 7 May 2026.